Thoratec Corp (NASDAQ:THOR)

CAPS Rating: 3 out of 5

The Company manufactures, develops and markets medical devices used for circulatory support.


Player Avatar TexasSue (< 20) Submitted: 12/29/2013 1:31:20 AM : Underperform Start Price: $36.13 THOR Score: +26.36

Thoratec Heartmate II devices say an increase in pump clots and death. Initial FDA reports were of clotting in about 1.2% .. which was true for a while.. during 2012 - for some unknown reasons the clot rate has shot up to 9% or higher depending on who's numbers you use. FDA investigation to pursue I would say.. and there are already class action lawsuits being filed due to the deaths.

Featured Broker Partners